SynthesisArthritis research & therapy2019

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data.

A Deodhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.